Nuvista Pharma PLC.

Nuvista Pharma PLC. (“NPL” or “the Company”) was originally a subsidiary of Netherlands-based Organon International. The Company has been operating in Bangladesh since 1964, with a local manufacturing facility at Tongi, Dhaka.

In 2018, Beximco Pharmaceuticals PLC., a public limited company listed with Bangladesh Stock Exchanges and AIM of London Stock Exchange, acquired majority shareholdings (85.22%) in Nuvista Pharma PLC.

Carrying the legacy of the quality and manufacturing excellence of Organon, the manufacturing facilities of the Company is currently producing hormones, steroids, and other general products in different dosage forms including tablets, capsules, injections, ophthalmic drops etc.